Vera Oppedijk

1.1k total citations · 2 hit papers
13 papers, 676 citations indexed

About

Vera Oppedijk is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Vera Oppedijk has authored 13 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Vera Oppedijk's work include Esophageal Cancer Research and Treatment (11 papers), Gastric Cancer Management and Outcomes (7 papers) and Esophageal and GI Pathology (6 papers). Vera Oppedijk is often cited by papers focused on Esophageal Cancer Research and Treatment (11 papers), Gastric Cancer Management and Outcomes (7 papers) and Esophageal and GI Pathology (6 papers). Vera Oppedijk collaborates with scholars based in Netherlands, United Kingdom and Germany. Vera Oppedijk's co-authors include Maarten C.C.M. Hulshof, Ate van der Gaast, Mark I. van Berge Henegouwen, Maurice J.C. van der Sangen, Patty H. Spruit, Janny G. Reinders, Heidi Rütten, Caroline M. van Rij, J. Jan B. van Lanschot and Jannet C. Beukema and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Surgical Oncology.

In The Last Decade

Vera Oppedijk

13 papers receiving 665 citations

Hit Papers

Patterns of Recurrence After Surgery Alone Versus Preoper... 2014 2026 2018 2022 2014 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials
    2014 340 citations Vera Oppedijk, Ate van der Gaast et al. Journal of Clinical Oncology profile →
  2. Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)
    2021 167 citations Maarten C.C.M. Hulshof, Elisabeth D. Geijsen et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Oppedijk Netherlands 8 547 531 121 66 43 13 676
Lea Choung Wong Singapore 10 192 0.4× 182 0.3× 140 1.2× 54 0.8× 53 1.2× 15 422
Andrew T. Wong United States 14 259 0.5× 141 0.3× 161 1.3× 59 0.9× 45 1.0× 30 439
Martin Leslie United Kingdom 7 503 0.9× 631 1.2× 348 2.9× 16 0.2× 16 0.4× 10 826
C. Llacer-Moscardo France 8 298 0.5× 291 0.5× 81 0.7× 18 0.3× 19 0.4× 15 369
Hans Geinitz Germany 11 306 0.6× 297 0.6× 73 0.6× 54 0.8× 68 1.6× 21 407
Shamus R. Carr United States 13 298 0.5× 123 0.2× 122 1.0× 60 0.9× 18 0.4× 38 477
Jinxing Yu United States 12 185 0.3× 300 0.6× 68 0.6× 87 1.3× 13 0.3× 20 489
Daniel J. Tandberg United States 9 232 0.4× 66 0.1× 84 0.7× 50 0.8× 46 1.1× 18 327
B. Burmeister Australia 9 316 0.6× 484 0.9× 208 1.7× 62 0.9× 69 1.6× 20 609
Jennifer A. Shannon Australia 5 124 0.2× 119 0.2× 150 1.2× 53 0.8× 28 0.7× 10 317

Countries citing papers authored by Vera Oppedijk

Since Specialization
Citations

This map shows the geographic impact of Vera Oppedijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Oppedijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Oppedijk more than expected).

Fields of papers citing papers by Vera Oppedijk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Oppedijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Oppedijk. The network helps show where Vera Oppedijk may publish in the future.

Co-authorship network of co-authors of Vera Oppedijk

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Oppedijk. A scholar is included among the top collaborators of Vera Oppedijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Oppedijk. Vera Oppedijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Jeene, Paul M., Héctor G. van den Boorn, Sherif Y. El Sharouni, et al.. (2022). Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagia. Acta Oncologica. 61(7). 849–855. 1 indexed citations
2.
Verhoeven, Rob H.A., Wouter B. Nagengast, Vera Oppedijk, et al.. (2022). Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival. European Journal of Surgical Oncology. 49(1). 106–112. 3 indexed citations
3.
Hulshof, Maarten C.C.M., Elisabeth D. Geijsen, Tom Rozema, et al.. (2021). Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study). Journal of Clinical Oncology. 39(25). 2816–2824. 167 indexed citations breakdown →
4.
Hulshof, Maarten C.C.M., Connie R. Jiménez, Edwin Cuppen, et al.. (2021). TGF-β and PD-L1 inhibition combined with definitive chemoradiotherapy in esophageal squamous cell carcinoma: A phase II clinical trial (NCT04595149).. Journal of Clinical Oncology. 39(15_suppl). TPS4154–TPS4154. 2 indexed citations
5.
Jeene, Paul M., Tom Rozema, Pètra M. Braam, et al.. (2020). Short-Course External Beam Radiotherapy Versus Brachytherapy for Palliation of Dysphagia in Esophageal Cancer: A Matched Comparison of Two Prospective Trials. Journal of Thoracic Oncology. 15(8). 1361–1368. 12 indexed citations
6.
Rossum, Peter S.N. van, Paul M. Jeene, Tom Rozema, et al.. (2020). Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: A matched comparison of two prospective trials. Radiotherapy and Oncology. 155. 73–79. 7 indexed citations
7.
Hulshof, Maarten C.C.M., Debby Geijsen, Tom Rozema, et al.. (2020). A randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study.. Journal of Clinical Oncology. 38(4_suppl). 281–281. 27 indexed citations
8.
Jeene, Paul M., Elisabeth D. Geijsen, Christina T. Muijs, et al.. (2019). Small Cell Carcinoma of the Esophagus. American Journal of Clinical Oncology. 42(6). 534–538. 22 indexed citations
9.
Jin, Peng, Jeanin E. van Hooft, Oliver J. Gurney‐Champion, et al.. (2019). Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers. Acta Oncologica. 58(6). 943–950. 14 indexed citations
10.
Mul, Véronique E., Walter Noordzij, T. Korteweg, et al.. (2017). Impact of Endoscopic Ultrasonography on 18F-FDG-PET/CT Upfront Towards Patient Specific Esophageal Cancer Treatment. Annals of Surgical Oncology. 24(7). 1828–1834. 5 indexed citations
11.
Jin, Peng, Oliver J. Gurney‐Champion, Elisabeth D. Geijsen, et al.. (2017). PO-0697: Reduced inter- and intra-observer variation in esophageal tumor delineation using fiducial markers.. Radiotherapy and Oncology. 123. S364–S365. 3 indexed citations
12.
Oppedijk, Vera, Ate van der Gaast, J. Jan B. van Lanschot, et al.. (2014). Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials. Journal of Clinical Oncology. 32(5). 385–391. 340 indexed citations breakdown →
13.
Jansen, Edwin P. M., Mark Saunders, Henk Boot, et al.. (2006). Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. International Journal of Radiation Oncology*Biology*Physics. 67(3). 781–785. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lea Choung Wong Breakdown of academic impact, for papers by Andrew T. Wong Breakdown of academic impact, for papers by Martin Leslie Breakdown of academic impact, for papers by C. Llacer-Moscardo Breakdown of academic impact, for papers by Hans Geinitz Breakdown of academic impact, for papers by Shamus R. Carr Breakdown of academic impact, for papers by Jinxing Yu Breakdown of academic impact, for papers by Daniel J. Tandberg Breakdown of academic impact, for papers by B. Burmeister Breakdown of academic impact, for papers by Jennifer A. Shannon
Rankless by CCL
2026